Pharmaxis says majority of patients in fibrosis trial see significant improvement
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips speaks with Proactive after releasing data from a final interim analysis of 10 patients who have...
Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips speaks with Proactive after releasing data from a final interim analysis of 10 patients who have...
Deep Dive - Pharmaxis Ltd
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company has made great progress towards commercialisation in a Phase 1C study of...
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has made great strides toward commercialisation in a Phase 1C study of its topical Pan LOX inhibitor, achieving...